¿Cómo dializamos a la Injuria Renal Aguda (IRA) en la Argentina? Resultados de una Encuesta Nacional

  • Fernando Lombi Servicio de Nefrología, Hospital Británico de Buenos Aires. Grupo de Trabajo de IRA, Sociedad Argentina de Nefrología
  • Gustavo Greloni Servicio de Nefrología, Hospital Italiano de Buenos Aires. Grupo de Trabajo de IRA, Sociedad Argentina de Nefrología
  • Guillermo Rosa Diez Servicio de Nefrología, Hospital Italiano de Buenos Aires. Grupo de Trabajo de IRA, Sociedad Argentina de Nefrología

Resumen

Introducción: La incidencia de injuria renal aguda (IRA) con requerimiento de diálisis ha aumentado en estos últimos años, con un alto impacto en términos de mortalidad y morbilidad. Objetivo: Nuestro objetivo fue realizar un diagnóstico de situación de las TRR aplicadas en IRA en nuestro país. Material y métodos: Se realizó una encuesta de carácter anónimo on-Iine por medio de un cuestionario de 22 preguntas con respuestas fijas. Resultados: Se analizaron 101 centros. El 90% de las terapias de reemplazo renal (TRR) se efectuaron en unidades críticas en el 67% de los centros. El 10% utiliza aún máquinas sin módulo de UF y un 3% utiliza acetato como solución de hemodiálisis. El agua utilizada en HD, fue en el 49% agua tratada en vasca o bidones y 2% agua sin o con tratamiento parcial. La membrana más utilizada fue la polisulfona 82%, (cuprofan en el 3%). El 90% y 73% de los encuestados no realizan ningún tipo de terapia continua o HD extendida respectivamente. Sólo 5% realizaron HD extendidas en más de la mitad de sus pacientes. 72% de los encuestados no cuenta con enfermeros con dedicación exclusiva para IRA. Conclusiones: Aún hay centros que utilizan membranas incompatibles, baño con acetato, agua parcialmente tratada o sin módulo de ultrafiltración. La TRR más utilizada es la hemodiálisis intermitente. La mayoría no aplica técnicas extendidas o continuas.

Citas

Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant. 2008;23(4):1117-21.

Szczech LA, Harmon W, Hostetter TH, Klotman PE, Powe NR, Sedor JR, et al. World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease. J Am Soc Nephrol. 2009;20(3):453-5.

Chertow GM, Soroko SH, Paganini EP, Cho KC, Himmelfarb J, Ikizler TA, et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int. 2006;70(6):1120-6.

Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73.

Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34(7):1913-7.

Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med. 2007;35(8):1837-43.

Lin CY, Chen YC, Tsai FC, Tian YC, Jenq CC, Fang JT, et al. RIFLE classification is predictive of short-term prognosis in critically ill patients with acute renal failure supported by extracorporeal membrane oxygenation. Nephrol Dial Transplant. 2006;21(10):2867-73.

Lopes JA, Jorge S, Resina C, Santos C, Pereira A, Neves J, et al. Prognostic utility of RIFLE for acute renal failure in patients with sepsis. Crit Care. 2007;11(2):408.

Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813-8.

Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med. 2002;30(9):2051-8.

Liaño F, Felipe C, Tenorio MT, Rivera M, Abraira V, Sáez-de-Urturi JM, et al. Long-term outcome of acute tubular necrosis: a contribution to its natural history. Kidney Int. 2007;71(7):679-86.

Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M, et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care. 2005;9(6):R700-9.

Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104(4):343-8.

Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365-70.

Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597-605.

Waikar SS, Liu KD, Chertow GM. The incidence and prognostic significance of acute kidney injury. Curr Opin Nephrol Hypertens. 2007;16(3):227-36.

Coca SG, Peixoto AJ, Garg AX, Krumholz HM, Parikh CR. The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. Am J Kidney Dis. 2007;50(5):712-20.

Hsu CY. Where is the epidemic in kidney disease? J Am Soc Nephrol. 2010;21(10):1607-11.

Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983;74(2):243-8.

Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930-6.

Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813-8.

Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17(4):1135-42.

Obialo CI, Okonofua EC, Tayade AS, Riley LJ. Epidemiology of de novo acute renal failure in hospitalized African Americans: comparing community-acquired vs hospital-acquired disease. Arch Intern Med. 2000;160(9):1309-13.

Liaño F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 1996;50(3):811-8.

Robertson S, Newbigging K, Isles CG, Brammah A, Allan A, Norrie J. High incidence of renal failure requiring short-term dialysis: a prospective observational study. QJM. 2002;95(9):585-90.

Metcalfe W, Simpson M, Khan IH, Prescott GJ, Simpson K, Smith WC, et al. Acute renal failure requiring renal replacement therapy: incidence and outcome. QJM. 2002;95(9):579-83.

Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol. 2006;17(4):1143-50.

Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1(5):915-9.

Liu KD, Matthay MA, Chertow GM. Evolving practices in critical care and potential implications for management of acute kidney injury. Clin J Am Soc Nephrol. 2006;1(4):869-73.

Hsu CY, McCulloch CE, Fan D, Ordoñez JD, Chertow GM, Go AS. Community-based incidence of acute renal failure. Kidney Int. 2007;72(2):208-12.

Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546-54.

Lucas FL, DeLorenzo MA, Siewers AE, Wennberg DE. Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001. Circulation. 2006;113(3):374-9.

Alter DA, Stukel TA, Newman A. Proliferation of cardiac technology in Canada: a challenge to the sustainability of Medicare. Circulation. 2006;113(3):380-7.

Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, De Metrio M, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med. 2009;150(3):170-7.

Ronco C, Bellomo R. Cardiorenal syndromes in critical care. Basel: Karger, 2010. (Contributions to Nephrology; 165).

Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008;1(3):200-8.

KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1):1-138.

Baldwin I, Naka T, Koch B, Fealy N, Bellomo R. A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance. Intensive Care Med. 2007;33(5):830-5.

Baldwin I, Bellomo R, Naka T, Koch B, Fealy N. A pilot randomized controlled comparison of extended daily dialysis with filtration and continuous veno-venous hemofiltration: fluid removal and hemodynamics. Int J Artif Organs. 2007;30(12):1083-9.

Davenport A. Continuous renal replacement therapies in patients with acute neurological injury. Semin Dial. 2009;22(2):165-8.

Bagshaw SM, Peets AD, Hameed M, Boiteau PJ, Laupland KB, Doig CJ. Dialysis Disequilibrium Syndrome: brain death following hemodialysis for metabolic acidosis and acute renal failure, a case report. BMC Nephrol. 2004;5:9.

Lin CM, Lin JW, Tsai JT, Ko CP, Hung KS, Hung CC, et al. Intracranial pressure fluctuation during hemodialysis in renal failure patients with intracranial hemorrhage. Acta Neurochir Suppl. 2008;101:141-4.

Ronco C, Bellomo R, Brendolan A, Pinna V, La Greca G. Brain density changes during renal replacement in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis. J Nephrol. 1999;12(3):173-8.

Modi GK, Pereira BJ, Jaber BL. Hemodialysis in acute renal failure: does the membrane matter? Semin Dial. 2001;14(5):318-21.

Alonso A, Lau J, Jaber BL. Biocompatible hemodialysis membranes for acute renal failure. Cochrane Database Syst Rev. 2008;(1):CD005283.

Honore PM, Jacobs R, Joannes-Boyau R, De Regt J, Boer W, De Waele E, et al. Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments. Ann Intensive Care. 2011;1:32-41.

Publicado
2012-12-10
Cómo citar
1.
Lombi F, Greloni G, Rosa Diez G. ¿Cómo dializamos a la Injuria Renal Aguda (IRA) en la Argentina? Resultados de una Encuesta Nacional. Rev Nefrol Dial Traspl. [Internet]. 10 de diciembre de 2012 [citado 29 de marzo de 2024];32(4):198-07. Disponible en: http://vps-1689312-x.dattaweb.com/index.php/rndt/article/view/227
Sección
Artículo Original